Sandra Hollander
Hematology & Oncology · Dublin, GANPI 1225168248
Payments from drug & device makers
Across 337 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$734
- Novartis$616
- Amgen$516
- Coherus Oncology, Inc.$448
- AstraZeneca$429
- Daiichi Sankyo Inc.$380
- plus $3K from 43 others
What the payments were for
- Food & beverage$5,51996%
- Education$2374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Udenyca$121
How this compares
$5,757 in reported general payments places this provider in the 45th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Dublin
- Mehmet BilenAtlanta$21.7M
- Steven McCuneMarietta$19.5M
- Ajay NookaAtlanta$19.3M
- Olatunji AleseAtlanta$15.5M
- Jonathon CohenAtlanta$8.7M
- Ticiana LealAtlanta$6.1M
- Amelia ZelnakCumming$4.4M
- Conor SteuerAtlanta$4.4M
- Anthony HunterAtlanta$4.3M
- Robert BrownAtlanta$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.